Dehydroepiandrosterone (DHEA)‐the “Mother Steroid”

Annals of the New York Academy of Sciences

Volumn 719, Issue 1, 1994, Pages 553-563

  Action, I Immunologic ^a   REGELSON, WILLIAM ^a   LORIA, ROGER ^a   KALIMI, MOHAMMED ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1; CORTICOSTEROID; GLUCOCORTICOID; INTERLEUKIN 2; INTERLEUKIN 6; ORNITHINE DECARBOXYLASE; PRASTERONE; PRASTERONE SULFATE;

ADRENAL GLAND; CELL PROLIFERATION; CELLULAR IMMUNITY; CONFERENCE PAPER; CUSHING DISEASE; DIET; EXERCISE; HORMONE BLOOD LEVEL; HORMONE STRUCTURE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; METABOLISM; NONHUMAN; PEROXISOME; PROTEIN PROCESSING; SARCOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMUS; VIRUS INFECTION;

EID: 0028309696     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb56859.x     Document Type: Article

References (79)

1. Hormonal intervention: “buffer hormones” or “state dependency.” The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging
2. Dehydroepiandrosterone (DHEA): the precursor steroid: introductory remarks
3. Dehydroepiandrosterone metabolic effects
4. Regulation of dehydroepiandrosterone (DHEA) metabolism by insulin and metabolic effects of dehydroepiandrosterone in man
5. Dehydroepiandrosterone: the “missing link” between hyperinsulinemia and atherosclerosis
6. Dehydroepiandrosterone (DHEA) and diabetic syndromes in mice
7. An adrenal secreted “androgen:” dehydroisoandrosterone sulfate. Its metabolism, and a tentative generalization on the metabolism of other steroid conjugates in man
8. DHEA: some thoughts as to its biologic and clinical action
9. Natural regulators of T‐cell lymphokine production in vivo.
10. Reversal of the immunosenes‐ cent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen
11. Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) as neural facilitators: effects on brain tissue in culture and on memory in young and old mice. A cyclic GMP hypothesis of action of DHEA and DHEAS in nervous system and other tissues
12. The neurosteroid DHEAS is an allosteric antagonist of the GABA receptor
13. Neurosteroids: a new brain function
14. Neurosteroids: 3β‐hydroxy‐ Δ5 derivatives in rat and monkey brain
15. Effect of DHEA on rodent liver microsomal mitochondrial and peroxisomal proteins
16. Hepatocarcinogenecity of dehydroepiandrosterone in the rat
17. DHEA and mitochondrial respiration
18. Inhibition of carbamyl phosphate synthetase‐I by dietary dehydroepiandrosterone
19. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease
20. The role of DHEA in obesity
21. DHEA effects on cholesterol and lipoproteins
22. Glucose‐6‐phosphate dehydrogenase and the relation of dehydroepiandrosterone to carcinogenesis
23. Studies of the biochemical action and mechanism of dehydroepiandrosterone
24. 3H‐thymidine uptake on human lymphocytes in vitro.
25. Inhibition of isoprenylation and p21 membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro.
26. DHEA and thymus integrity in the mouse
27. The influence of cold and isolation stress on resistance of mice to West Nile virus encephalitis
28. Protection from glucocorticoid‐ induced thymic involution by dehydroepiandrosterone
29. Immune response facilitation and resistance to viral and bacterial infections with DHEA
30. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA)
31. Basal serum dehydroepi androsterone sulfate concentration predicts the Cortisol response to provocative testing
32. Serum steroid levels in two old men with Alzheimer's disease (AD) before, during, and after oral administration of dehydroepiandrosterone (DHEA). Pregnenolone synthesis may become rate‐limiting in aging
33. Inverse relation between low density lipoprotein‐choles‐terol and dehydroepiandrosterone sulfate in human fetal plasma
34. Identification and isolation of dehydroisoandrosterone from peripheral human plasma
35. Sex differences in the twenty‐four‐hour mean plasma concentrations of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) and the DHEA to DHEAS ratio in normal adults
36. Pattern of plasma dehydroepiandrosterone sulfate levels in human from birth to adulthood: evidence for testicular production
37. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex, day to day and diurnal variations
38. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
39. Dehydroepiandrosterone and two structural analogs inhibit 12‐0‐tetra‐decanoylphorba‐13‐acetate stimulation of prostaglandin G2 content in mouse skin
40. Protection of dehydroepiandrosterone (DHEA) in mice infected with viral encephalitis
41. Androstenediol regulates systemic resistance against lethal infections in mice
42. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of IL‐2 synthesis by helper T‐cells
43. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factor interleukin 2 and interleukin 4
44. Dehydroepiandrosterone enhances IL‐2 production and cytotoxic effector function of human T‐cells
45. Regulation of murine lymphokine production in vivo. III. The lymphoid microenvironment exerts regulatory influences over T helper function
46. Effect of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Crytosporidium parvum
47. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence
48. Stimulation of interleukin production by corticotrophin releasing factors
49. Thymic modulation of IL‐2 and IL‐4 synthesis by peripheral T cells
50. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation
51. Differential effects of dehydroepiandrosterone on murine lymphopoiesis and myelopoiesis
52. Food intake reduction and immunologic alteration in mice fed dehydroepiandrosterone
53. Dehydroepiandrosterone prevention of autoimmune disease in NZB/WF1 mice: lack of an effect on associated immunological abnormalities
54. Low sulpho‐conjugated steroid hormone levels in systemic lupus erythematosus (SLE)
55. Reduced weight gain and delay of Coomb's positive hemolytic anemia in NZB mice treated with dehydroepiandrosterone (DHEA)
56. Inhibition of cardiac allograft atherosclerosis by dehydroepiandrosterone
57. Increase in plasma 5a‐androstane‐3α, 17/3‐ diol glucoronide as a marker of peripheral androgen action in hirsutism: a side effect induced by cyclosporine A
58. Mechanism of chemoprevention by dietary dehydroepiandrosterone. Inhibition of lymphopoiesis
59. Hormonal regulation of complement biosynthesis in human cell lines. I. Androgens and gamma‐interferon stimulate the biosynthesis and gene expression of CI inhibitor in human cell lines U937 and HepG2.
60. Dehydroepiandrosterone and two structural analogs inhibit 12‐O‐tetra‐decanoylphorba‐13‐acetate stimulation of prostaglandin E2 content in mouse skin
61. Dehydroepiandrosterone and 16a‐bromoepiandrosterone: inhibitions of Epstein‐Barr virus induced transformation of human lymphocytes
62. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV IIIB replication
63. Effects of dehydroepiandrosterone in lymphocytes and macrophages infected with human immunodeficiency virus
64. Hyperandrogenism originating from the adrenal gland. Current observations on a clinical case
65. Decreased dehydroepiandrosterone sulfate in pigmented nodular adrenal dysplasia
66. The relationship of serum DHEA‐S and Cortisol levels to measures of immune function in human immunodeficiency virus related illness
67. Effects of syphilis infection on adrenocortical function in man
68. Sex hormones in postmenopausal HLA‐identical rheumatoid arthritis discordant sibling pairs
69. Modulation of growth, differentiation, and carcinogenesis by dehydroepiandrosterone
70. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents
71. Reduced plasma dehydroepiandrosterone concentration in HIV infection and Alzheimer's disease
72. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200‐499
73. Abnormalities of morning serum Cortisol levels and circadian rhythms of CD4+ lymphocyte counts in human immunodeficiency virus type 1 infected adult patients